Dry eye disease in type 2 diabetes mellitus; comparison of the tear osmolarity test with other common diagnostic tests: A diagnostic accuracy study using STARD standard by Najafi, L. et al.
Najafi et al. Journal of Diabetes & Metabolic Disorders  (2015) 14:39 
DOI 10.1186/s40200-015-0157-yRESEARCH ARTICLE Open AccessDry eye disease in type 2 diabetes mellitus;
comparison of the tear osmolarity test with other
common diagnostic tests: a diagnostic accuracy
study using STARD standard
Laily Najafi1, Mojtaba Malek1, Ameneh Ebrahim Valojerdi1, Mohammad E Khamseh1* and Hossein Aghaei2Abstract
Background: To determine the diagnostic performance of tear osmolarity in diagnosis of dry eye disease by using
tear lab osmolarity system in people with type 2 diabetes, and to compare it with common diagnostic tests already
available in clinical practice.
Methods: Two hundreds forty three people with type 2 diabetes were included. Tear osmolarity was measured
with the tear osmolarity system. The 308 mOsm/L cutoff was used to diagnose dry eye disease. The following tests were
also performed: Ocular Surface Disease Index (OSDI) questionnaire, Tear Film Break up Time (TFBUT), Schirmer I test, Rose
Bengal and Fluorescein staining. The results of these tests were compared to the tear osmolarity measurement.
Results: The prevalence of dry eye disease detected by the tear osmolarity test was 27.7%. It was as follows for the other
common diagnostic tests: OSDI (17.7%), Schirmer I test (33%), TFBUT (41%), Rose Bengal (11%), and Fluorescein staining
(4%). Fluorescein staining had the highest specificity (97%). With the cutoff score >12, the positive likelihood ratio for the
OSDI questionnaire was the highest (1.78). The sensitivity was poor for all common diagnostic tests. ROC curve analysis
could not determine optimal cut offs for the common diagnostic tests.
Conclusions: The available common diagnostic tests underestimate the presence of dry eye disease in people with type
2 diabetes. Moreover, they could not discriminate tear hyperosmolarity from normal. Tear osmolarity could be
considered as the best single test for detection of dry eye disease in people with type2 diabetes.
Keywords: Diabetes mellitus, Dry eye disease, Diagnostic accuracy Study, STARDIntroduction
In adult population, dry eye disease (DED) is a common
ocular disease and has been recognized as an important
public health problem in recent years [1-3].
Although our knowledge about its pathogenesis, classi-
fication, and characteristics has grown considerably over
the past decade, there are still debates on diagnostic ap-
proach. This is mainly due to the lack of objective tests
with sufficient sensitivity and specificity that could be* Correspondence: khamseh.m@iums.ac.ir
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unless otherwise stated.applied easily in routine clinical care settings and at the
same time be adequately reproducible [4,5].
Schirmer I test, tear film break-up time (TFBUT) ana-
lysis, Rose Bengal and fluorescein staining are the most
well-known objective tests used for diagnosis of DED
[6]. However, neither symptoms nor signs always match
with the results of these tests [7].
Tear osmolarity measurement by freezing point de-
pression technique has been proposed as the gold stand-
ard test for diagnosis of DED [8], however, the problems
associated with the existing technologies hindered its
use in clinical practice [9]. Moreover, it is costly, time-
consuming; and requires tear volumes much higher than
those collectable in several forms of dry eye disease, or
inducing excessive reflex tearing during tear sampling.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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barriers. It measures tear osmolarity based on electrical
impedance technique and the results correlate well with
the gold standard freezing point depression technique [9].
Several previous studies, investigated the relationship
between diabetes and DED [10]. It has shown that com-
position of tear proteins in people with diabetes is differ-
ent from healthy subjects [11]. In diabetes mellitus
corneal and conjunctival epithelial alterations, persistent
epithelial defects, and potential visual impairment due to
corneal scaring have been observed [12-18]. Damage to
the microvasculature of the lacrimal glands accompanied
with autonomic neuropathy could impair lacrimation in
long standing diabetes [19].
The purpose of the present work was to determine the
diagnostic performance of tear osmolarity test; used to
diagnose DED in type 2 diabetes mellitus using tear lab
osmolarity system as the reference standard and to com-
pare it with the other diagnostic tests (index tests)
already in use, specifically Ocular Surface Disease Index
(OSDI) questionnaire, Schirmer I test, TFBUT, Rose
Bengal and fluorescein staining.Methods
We prospectively enrolled 243 consecutive diabetic pa-
tients at the Institute of endocrinology and metabolism
between August 2011 and November 2012.
Exclusion criteria include use of medications or history
of any other ocular or systemic disease that can affect
tear production or quality, history of anterior segment
surgery, Keratorefractive procedures (LASIK, LASEK,
PRK) within one year prior to enrollment, trauma, contact
lens wear, incomplete lid closure, entropion, ectropion,
nasolachrymal drainage obstruction, punctual plugs place-
ment, or cauterization; ocular allergy, glaucoma, pregnancy
or lactation, and use of ocular medications or nutritional
tear supplements.
All of the participants underwent a general physical
examination and a thorough ophthalmologic exam. The
visual acuity of both eyes was tested using Snellen’s
chart. Both eyes were examined first using the board
beam of the slit lamp to know the condition of the ocu-
lar surface and adenexa, observing the tear film menis-
cus, tear film, corneal changes, conjunctival changes,
and eyelids. They were also clinically evaluated with dir-
ect and indirect ophthalmoscopy to know the status of
retina. The study population underwent tear osmolarity
test (standard test) before the Ocular Surface Disease
Index (OSDI) questionnaire, Schirmer I test, Rose Bengal
and fluorescein staining, and tear film break-up time test
(TFBUT) (index tests); all were performed on the same
day. All of the tests were performed according to the
randomization table for one eye.OSDI questionnaire was administrated to the partici-
pants by a research associate trained by an expert oph-
thalmologist to score the questions and to follow the
ambiguous information. Schirmer I test, Rose Bengal,
fluorescein staining, TFBUT were performed for all of
the participants by an expert ophthalmologist in con-
secutive sessions. Tear osmolarity test was done by a
single specialist. The investigators were blinded to the
patients’ history and the obtained information.
To avoid diagnostic error, all of the examinations were
performed in the same physical condition and in the
morning to standardize the tests and to avoid possible
diurnal variation. Assessments were made in a room
controlled for enlightment (dim light), temperature, hu-
midity, and airflow, to avoid ocular surface stress. The
tests that need slit lamp were performed in a darkened
room with the same slit lamp and by the same physician.
Tear osmolarity was measured using tear lab osmolar-
ity system, (BON Co. Germany). The Tear lab instru-
ment is based on a lab- on – a- chip technology working
as both a collection device and an analytical system, in
absence of any chemical reagent. This avoids the need
for a capillary tube or absorbing acetate disc. The equip-
ment consists of single use test cards containing micro-
channels to collect tear fluid, held by a pen designed to
facilitate tear collection, and a portable reader unit
which elaborates and displays the osmolarity results. A
tear sample, approximately 50 nl, was collected from the
inferior lateral tear meniscus of the ocular surface. To
facilitate tear collection, patients were asked to position
their head laterally for a few seconds before approaching
the tip of the test card microchip: in this way, tears were
driven laterally and collection made easier. Subjects had
been requested not to wear makeup on their eyelids.
Quality control procedures were applied at the begin-
ning of each day of patient testing by using reusable
electronic check cards (provided by the manufacture as
a procedural quality control) to confirm the function
and calibration of the TearLab osmolarity system. The
308 mOsm/L cutoff was used to diagnose DED [20]. At
this diagnostic cutoff, osmolarity was found to have 88%
specificity, 75% sensitivity in mild/moderate disease and
95% sensitivity in severe disease [20].The very rapid ac-
quisition of tear samples by the TearLab would be less
likely to be influenced by evaporation.
The OSDI questionnaire has a Likert design and as-
sesses frequency of ocular subjective symptoms (soreness,
blurred vision), difficulty with vision-related function (tele-
vision, visual display unit, driving, reading) and discomfort
due to environmental triggers (low humidity, high wind).
The patients answer 12 questions, with higher scores
representing greater disability [21].
Subjective symptoms of dry eye were graded on the
basis of dry eye discomfort symptoms questionnaire
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ity), 13–22 (light dry eye), to 23–32 (moderate dry eye),
and 33–100 (sever dry eye) [9].
Schirmer I test and TFBUT were carried out as out-
lined in the DEWS report [4].
The Schirmer test is an invasive and indirect method
to measure change in volume of the tears in the tear res-
ervoir. This test involves insertion of a wick into the lower
conjunctival sac and measurement of the wetting length
over a set period of time. The Schirmer test uses filter pa-
pers to assess tear production. There are two commonly
used variations of the Schirmer test: Schirmer I measures
total tear secretion (reflex and basal tears) and Schirmer II
utilizes anesthetic to measure basal secretions, although
this has not been validated [22-24].
The strip was folded at the notch and placed at the junc-
tion of the middle and lateral thirds of the lower eyelids
and allowed there to stay in place for 5 minutes [25].
A value of less than 5 mm wetting in 5 minutes is con-
sidered abnormal, more than 10 mm per 5′ seconds as
normal and 6-10 mm per 5′seconds as borderline [4].
Medial and lateral placements of the paper have been
described, as well as having the patient looking up, but
no method has been deemed more reliable [26].
TFBUT is the standard test for estimating tear film
stability. The results are explained as seconds. Patients
with break-up time of more than ten seconds was con-
sider as normal, those with less than ten seconds was la-
beled as unstable tear film, 6 to 10 seconds as moderate
dry eye disease, and ≤5 sec as sever dry eye disease [9].
The TFBUT was performed by applying a fluorescein
strip after moistening it with a drop of sterile saline, to
the lower tarsal conjunctiva without the use of topical
anesthesia. The time lapse between the last blink to the
appearance of the first random dry spot was taken as the
tear film break up time [25].
Epithelial damage to the exposed surface of the eye
can be demonstrated with vital and supra-vital stains.
Fluorescein and Rose Bengal staining are the standard
but invasive methods used to demonstrate ocular surface
damage. This technique reveals surface damage on both
the cornea and conjunctiva [27].
The eye is best viewed with anexciter (Wratten 47/47a;
Edmund Optics, Barrington, NJ, USA) and barrier filter
(Wratten 12/15) to assess staining on the cornea and
conjunctiva.
Evaluation of staining is highly subjective, but the use
of charts such as the Oxford grading scheme can help
by enabling consistent recording of staining severity and
is used to estimate surface damage in dry eye. The
scheme has five panels, labeled A–E, with staining repre-
sented by punctuate dots that increase logarithmically
between the panels [28]. The clinician compares the ap-
pearance of staining on the exposed interpalpebralconjunctiva and cornea with each panel and the closest
match determines the grade. On a specially designed
form, a grade between 0 and 3was given for staining on
the cornea, based on the number of “dots” seen, which
was to be added to a grade between 0 and 3 for the nasal
and the same for the temporal conjunctiva. This gave a
maximum possible total of 9 points. Three additional
points were then allocated for fluorescein only if there
was confluent staining (+1), staining in the papillary area
(+1), or one or more filaments (+1), giving a maximum
possible score of 12. This was performed for each eye. An
abnormal score was considered to be 3 and above [21].
The study was approved by the local ethical committee
of Tehran University of Medical Sciences and conducted
in accordance with the ethical principles of the Declar-
ation of Helsinki and all of the participants signed the
written informed consent.
Statistical analysis
Statistical analysis was performed using Statistical Package
for Social Sciences (SPSS, SPSS Inc., Chicago, IL, USA)
version 18.0. Descriptive statistics were summarized as
mean ± SD, or median and interquartile. Kolmogorov
Smirnov was performed to assess normality for continu-
ous variables.
An evaluation was made of the linear relationship be-
tween the tear osmolarity values and TFBUT, OSDI score,
Schirmer I test and Rose Bengal and fluorescein staining.
This was performed by using Spearman’s correlation coef-
ficient (rho). Student’s t test and Mann–Whitney U test
was applied for comparisons between two groups (signifi-
cance p < 0.05).
Chi square test was used to compare discrete variables.
Results were given with their 95% CIs.
Diagnostic accuracy tests was performed to analyze
sensitivity, specificity, receiver operating characteristic
(ROC) curves, positive likelihood ratio (LR+), and posi-
tive predictive values (PPV).
Results
From August 2011 until November 2012, we prospect-
ively enrolled 243 people with type 2 diabetes at Institute
of endocrinology and metabolism. Four patients were ex-
cluded from the study for the following reasons: LASIK
within the 1 year prior to enrollment (2), contact lens wear
(1), and glaucoma (1).
The data from 137 female and 102 male were used for
the final analysis. The mean age was 55.8 ± 10.33 years old,
and the mean duration of diabetes was 9.08 ± 7.9 years. The
mean for fasting blood glucose was 152.4 ± 59.6 mg/dl, and
for HbA1C was 7.55% ± 1.73%. Oral glucose lowering drugs
(OGLDs) were used by 69.4% of the participants, while
10.5% were on insulin only, and 15.5% were on OGLDs
plus insulin.
Table 2 Comparison of the OSDI, Schirmer I test, Rose
Bengal staining, fluorescein staining, and TFBUT test
results between the two groups
All
participants
DED group Normal
group
P-value
(n = 67) (n = 172)
OSDIa (score) 2.08 (0, 8.3) 2.08 (0, 14.58) 2.08 (0, 8.3) 0.44
Fluorescein
staining (score)
0 (0, 0) 0 (0, 0) 0 (0, 0) 0.70
Rose Bengal
staining (score)
0 (0, 1) 0 (0, 1.25 ) 0 (0, 1) 0.13
Schirmer I
test (mm)
5 (2, 10) 6 (2, 11) 5 (2, 10) 0.64
TFBUTb (secs) 8 (5, 12.25) 9 (5,13.25 ) 8 (5,12) 0.27
aOSDI, Ocular Surface Disease Index.
bTFBUT, Tear film break-up time.
For all variables, data are shown as Median (Interquartile), Kolmogorov
Smirnov normality test distribution.
Statistical method: Mann–Whitney test.
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formed at the first attempt in all participants; no reflex tear-
ing was observed in any subjects. Considering of dry eye
disease definition; two groups were identified: the dry eye
disease (DED) group (67), and the normal group (172). All
of the analyses were done considering this classification.
Table 1 illustrates clinical characteristics of the partici-
pants, according to the tear osmolarity test categorization.
The mean value for the tear osmolarity in all of the
participants was 301.97 ± 13.52 mOsm/L. This value was
319.03 ± 7.92 mOsm/Lin the DED group and 295.38 ±
8.49 mOsm/Lin the normal group.
The prevalence of DED detected by the tear osmolarity
test was 27.7% (10.2% in male, and 17.5% in female).
The prevalence of DED detected by the other five diag-
nostic tests was as follows: OSDI (17.7%), Schirmer I test
(33%), TFBUT (41%), Rose Bengal (11%), and fluorescein
staining (4%).
Comparison of the results for all of the applied tests
showed statistically non-significant difference between
the two groups which is mentioned in Table 2.
We also compared the discriminative ability of the
OSDI, Schirmer I test, Rose Bengal and fluorescein
staining, and TFBUT tests results in Table 2 to detect
DED compared to the tear osmolarity test.
Considering adverse events, only three patients re-
ported eye discomfort following conjugate staining for a
few hours.
Due to technical failure, we could not interpret the
test results for Schirmer I test and TFBUT in ten sub-
jects. In addition performing ophthalmic tattoos was the
reason for indeterminant test results in two subjects.Table 1 Clinical characteristics of the participants
All
participants
DEDd
group
Normal
group
P-value
(n = 67) (n = 172)
Age (yrs.)
Mean ± SD 55.8 ± 10.33 56.50 ± 9.47 55.43 ± 10.66 0.48
Range 22-84 37-81 22-84
Gender (female)
n (%)
137 (58%) 42(64%) 95(56%) 0.28
BMIa (kg/m2) 29.2 ± 4.9 29.42 ± 5.36 29.36 ± 5.12 0.94
Diabetes
duration (yrs.)
9.08 ± 7.9 9.73 ± 8.25 8.71 ± 7.69 0.32
FBSb (mg/dl) 152.4 ± 59.6 163.63 ±
61.27
147.44 ±
59.61
0.09
HbA1cc (%) 7.55 ± 1.73 7.94 ± 1.87 7.14 ± 1.66 0.054
aBMI, Body Mass Index.
bFBS, Fasting blood sugar.
cHbA1C, Hemoglobin A1C.
dDED, Dry eye disease.
Data are mean ± SD unless otherwise indicated.
Statistical method: Mann–Whitney test, Independent sample t-test and χ2 –test.The correlation coefficient for the measured tear
osmolarity and the results of the other diagnostic tests
were calculated in Table 3. No significant correlation
was found.
The diagnostic performance for all of the diagnostic
tests was determined. Data were summarized for sensi-
tivity, specificity, positive predictive value (PPV), likeli-
hood ratio (LR+), and area under the curve (AUC) from
the ROC curve analysis in Table 4.
Fluorescein staining had the highest specificity (0.97),
however its sensitivity was the lowest (0.05). With OSDI
cutoff score of more than 12; the AUC was 0.558 which
was the highest value compared to those found for the
other tests. With this cutoff the positive likelihood ratio
and PPV values were also the highest (1.78, and 0.4 re-
spectively). The specificity value was also considerably
high (0.85), behind that shown by the Rose Bengal stain-
ing (cut-off ≥ 3, specificity = 0.90) (Table 5).
We also tried to determine the cutoffs for all index
tests with an optimal sensitivity and specificity in dia-
betic patients using ROC curve analysis in Figure 1, but
we could not define any optimal cutoff value.Discussion
As far as we searched the literature, this study was the
first to compare the diagnostic performance of the tear
osmolarity test to the other diagnostic tests used in clin-
ical practice for detection of dry eye disease in people
with type 2 diabetes mellitus. Our results revealed no
significant correlation between tear osmolarity and the
other diagnostic tests. OSDI had the highest AUC value
with high LR+, PPV and specificity. However, it could
not be suggested as a screening test due to its low
sensitivity.
Table 3 DED detection rate by OSDI, Schirmer I test, Rose Bengal, fluorescein staining, and TFBUT compared to tear
osmolarity test
OSDIa Schirmer I test Rose Bengal staining Fluorescein
staining
TFBUTb
Dry eye disease (n = 67) 14(20.8%) 20(29.8%) 8(11.9%) 3(4.4%) 27(40.2%)
Normal (n = 172) 21(12.2%) 48(27.9%) 14(8.1%) 5(2.9%) 57(33.1%)
aOSDI, Ocular Surface Disease Index.
bTFBUT, Tear film break-up time.
Data are n. (%).
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lems causing discomfort, deterioration in visual quality,
and increased risk of infection [29]. Hosotani et al. [30],
observed decreased tear production in diabetic patients.
Goebbels M [31] suggested that amount of the reflex
tearing is lower in the diabetics which can be due to di-
minished corneal and conjunctival sensations or may be
due to neuropathy involving the lacrimal glands.
The lack of concordance between signs and symptoms
in DED is a problem in the diagnosis of the disease. So,
we need a reliable test or a group of tests that could be
able to diagnose DED [9].
The current practical methods for diagnosing of DED
such as corneal and conjunctival staining, Schirmer
testing, and TFBUT are time-consuming and uncom-
fortable. Meanwhile, they could not predict symptom-
atic outcomes [32].
A new and reliable technology, tear osmolarity meas-
urement can now is considered as a test suitable to be
performed in clinical setting. The diagnostic accuracy of
tear osmolarity test was found to be higher than the
other tests [9].
Tear osmolarity, at a cutoff of more than 308 mOsms/L,
achieved a 90.7% rate of proper diagnosis regarding severe
dry eye patients in comparison with the other cutoff
values (>314 mOsms/L; 86.7% and >311 mOsms/L;
89.3%), and also at the mentioned cutoff, a 73.2% rate of
proper diagnosis was achieved regarding mild to moderate
stage of dry eye. So, tear osmolarity is the most useful sin-
gle objective test among the most commonly used tests to
differentiate those with mild or moderate dry eye from
those with sever disease. A cutoff threshold of more thanTable 4 Correlation coefficient of the tear osmolarity and
other diagnostic tests
Variable Correlation coefficients (r) P-value
Rose Bengal staining 0.12 0.08
OSDIa 0.11 0.11
TFBUTb 0.08 0.26
Fluorescein staining −0.06 0.41
Schirmer I test −0.04 0.54
aOSDI, Ocular Surface Disease Index.
bTFBUT, Tear film break-up time.
Statistical method: Spearman’s correlation coefficient (rho).308 mOsms/L was found to be the most sensitive in differ-
entiating normal from mild to moderate subjects [5].
In a comparison case- control study of diagnostic tests
in keratoconjunctivitis sicca with a small sample size;
tear osmolarity determination had 90% sensitivity and
95% specificity; while the Schirmer test yielded 25% sen-
sitivity and 90% specificity [33].
In another study, tear osmolarity was found to have a
72.8% sensitivity and 92% specificity at a cutoff value of
312 mOsms/L, while corneal staining showed 54% sensi-
tivity and 89.3% specificity, conjunctival staining 60.3%
sensitivity and 90.7% specificity, TFBUT (cutoff value <10
secs) 84.4% sensitivity and 45.3% specificity, and Schirmer
(cutoff value <18 mm) 79.5% sensitivity and 50.7% specifi-
city [5].
In contrast with our findings; a diagnostic study in pa-
tients with Sjogern’s syndrome revealed that the diag-
nostic usefulness of Schirmer’s I test was inferior to that
of TFBUT. The sensitivity and specificity were 80% and
53% respectively at a cutoff value of 5 mm in compari-
son with 88% and 35%, at a cutoff value of 10 mm [34].
The Schirmer test is a useful screening method for diag-
nosing lachrymal hyposecretion, but not for determination
of the tear production threshold. Its sensitivity is between
10% and 30% [35,36]. In diabetes patients, the Schirmer
test exhibits lower value than normal values [37,38]. In a
series by Dogru [39], 22.7% of the eyes impregnated the
strip less than 5.5 mm. In Gupta [25] and Ozdemir [40]
series 9 and 34 percent of the eyes had Schirmer I value
lower than 5 millimeters respectively.
The results of another study designed in six subgroups
(Sjogern’s syndrome, graft-versus-host disease, Graves
orbitopathy, facial palsy, diabetes mellitus without prolifer-
ative retinopathy and glaucoma who chronically received
topical drugs preserved with benzalkonium chloride) asso-
ciated with dry eye disease were as follows: The most sen-
sitive test was OSDI while the least accurate was lissamine
green staining . The The best combination of tests to
achieve the highest combined sensitivity (100%, C.I 95%
97.5–100), specificity (95%, C.I. 95% 75.1–99.9) and accur-
acy (99.3 C.I. 95% 96–99.9) for DED diagnosis was OSDI/
TBUT/Schirmer test. The values (% and CI of 95%.) of sen-
sitivity for the DED tests in diabetic patients for all tests
were as follows: OSDI = 69.2 (38.6–90.9), Osmolarity = 78.2
Table 5 Diagnostic performance of all index tests
Cut- off value Sensa (%) Specb(%) AUC c**(95% Confidence Interval) LR+d PPVe (%)
OSDI >12 score 25.93 85.42 0.558 (0.464-0.651) 1.78 0.4
Fluorescein staining ≥3 score 5.17 96.64 0.509 (0.421-0.597) 1.54 0.37
Rose Bengal staining ≥3 score 13.79 90.60 0.522 (0.433-0.611) 1.47 0.36
Schirmer I test ≤10 mm 34.48 67.57 0.507 (0.415-0.598) 1.06 0.29
TFBUT ≤10 secs 46.55 61.49 0.535 (0.443-0.627) 1.21 0.32
aSens: Sensitivity; bSpec: Specificity, cAUC: Area under the curve; dLR+: Likelihood ratio; ePPV+: Positive predictive value.
Statistical method: Diagnostic accuracy tests.
**No significant p-value in AUC was detected.
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(23.4–83.2), and fluorescein staining = 21.4 (4.67–50.1) [41].
Besides bias due to population characteristics, the wide
ranges in tear osmolarity results could be attributed to
technical characteristics of the instruments and to tear
collection methods, which introduce a significant and
uncontrolled variable in the measurement of tear osmo-
larity. Trying to collect the tear volumes needed for
measurements (sample size of 0.5 to 1.0 μl or larger)
often results in reflex tearing, which dilutes samples and
invalidates the results. Moreover, many patients with dry
eye may not be evaluated due to the impossibility to
properly collection of enough tear samples [9].
The strengths of this study is being the first one con-
ducted in people with type 2 diabetes and including ad-
equate sample size to produce reliable conclusion and
influenced the degree of generalizability of the results.
A common criticism for estimating sensitivity, specifi-
city, and prevalence without a gold standard is that,
without a gold standard, it is difficult to conceptualize
sensitivity and specificity [42]. But here we used goldFigure 1 The ROC curve obtained for common diagnostic tests in dry eyestandard to lessen the problem of conceptualizing
the truth.
Potential limitations of the study include the fact that
we did not consider social and environmental context of
the study population; race/ethnicity or season. It is not
yet known the extent to which these variables affect the
distribution of osmolarity in normal persons or dry eye
disease patients.
Also we are aware that studies of diagnostic accuracy
are not the only type of studies to evaluate diagnostic
tests.
Conclusions
In conclusion, available common diagnostic tests for
evaluation of dry eye disease underestimate the problem
in people with type 2 diabetes. Moreover, they could not
properly discriminate normal condition from tear hyper-
osmolarity and the severity of dry eye disease. So, direct
measurement of the tear osmolarity could be considered
as a suitable test for detection of dry eye disease in
people with type 2 diabetes., using tear osmolarity as the gold standard.
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